Angiogenesis in metabolic-vascular disease
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
Angiogenesis, literally formation of new blood vessels, is the main process through which the vascular system expands during embryonic and postnatal development. Endothelial cells, which constitute the inner lining of all blood vessels, are typically in a quiescent state in the healthy adult organism. However, in vascular and metabolic diseases, the endothelium becomes unstable and dysfunctional. The resulting tissue hypoxia may thereby induce pathological angiogenesis, which is a hallmark of disease conditions like cancer or diabetic retinopathy. However, recent evidence suggests that angiogenesis is also a major player in the context of further metabolic diseases, especially in obesity. In particular, deregulated angiogenesis is linked with adipose tissue dysfunction and insulin resistance. On the other hand, signalling pathways, such as the PI3K pathway, may regulate metabolic activities in the endothelium. Endothelial cell metabolism emerges as an important regulator of angiogenesis. This review summarises the role of angiogenesis in metabolic-vascular disease, with specific focus on the role of angiogenesis in obesity-related metabolic dysfunction and on signaling pathways, especially PI3K, linking cell metabolism to endothelial function.
Details
Original language | English |
---|---|
Pages (from-to) | 1289-1295 |
Number of pages | 7 |
Journal | Thrombosis and Haemostasis |
Volume | 117 |
Issue number | 7 |
Publication status | Published - 2017 |
Peer-reviewed | Yes |
External IDs
researchoutputwizard | legacy.publication#79409 |
---|---|
Scopus | 85021638033 |
PubMed | 28594427 |
ORCID | /0000-0002-9467-780X/work/147674929 |
Keywords
Sustainable Development Goals
ASJC Scopus subject areas
Keywords
- Angiogenesis, Diabetes, Glycolysis, Insulin resistance, Metabolism, Obesity, PI3-kinase